Averil Griffith

Invasive pneumococcal disease surveillance in Canada, 2023.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: April 02, 2026

Invasive Group A Streptococcus Hypervirulent M1UK Clone, Canada, 2018-2023.

Journal: Emerging infectious diseases

Published: October 20, 2024

Invasive group A streptococcal disease surveillance in Canada, 2021-2022.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: June 05, 2024

Invasive pneumococcal disease surveillance in Canada, 2021-2022.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: June 05, 2024

International circumpolar surveillance: update on the interlaboratory quality control program for Streptococcus pneumoniae, 2009 to 2020.

Journal: Microbiology spectrum

Published: April 23, 2024

Group A streptococcal outbreak in a geriatric mental health unit.

Journal: American journal of infection control

Published: April 07, 2024

Invasive group A streptococcal disease surveillance in Canada, 2020.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: September 01, 2022

Invasive pneumococcal disease surveillance in Canada, 2020.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: September 01, 2022

Linear Regression Equations To Predict β-Lactam, Macrolide, Lincosamide, and Fluoroquinolone MICs from Molecular Antimicrobial Resistance Determinants in Streptococcus pneumoniae.

Journal: Antimicrobial agents and chemotherapy

Published: October 18, 2021

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.

Journal: Vaccine

Published: January 15, 2018

PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F.

Journal: Journal of microbiological methods

Published: October 24, 2017

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

Journal: Canadian journal of microbiology

Published: December 10, 2013

Invasive pneumococcal disease surveillance in Canada, 2023.

Invasive pneumococcal disease surveillance in Canada, 2023.

Invasive Group A Streptococcus Hypervirulent M1UK Clone, Canada, 2018-2023.

Invasive Group A Streptococcus Hypervirulent M1UK Clone, Canada, 2018-2023.

Invasive group A streptococcal disease surveillance in Canada, 2021-2022.

Invasive group A streptococcal disease surveillance in Canada, 2021-2022.

Invasive pneumococcal disease surveillance in Canada, 2021-2022.

Invasive pneumococcal disease surveillance in Canada, 2021-2022.

International circumpolar surveillance: update on the interlaboratory quality control program for Streptococcus pneumoniae, 2009 to 2020.

International circumpolar surveillance: update on the interlaboratory quality control program for Streptococcus pneumoniae, 2009 to 2020.

Group A streptococcal outbreak in a geriatric mental health unit.

Group A streptococcal outbreak in a geriatric mental health unit.

Invasive group A streptococcal disease surveillance in Canada, 2020.

Invasive group A streptococcal disease surveillance in Canada, 2020.

Invasive pneumococcal disease surveillance in Canada, 2020.

Invasive pneumococcal disease surveillance in Canada, 2020.

Linear Regression Equations To Predict β-Lactam, Macrolide, Lincosamide, and Fluoroquinolone MICs from Molecular Antimicrobial Resistance Determinants in Streptococcus pneumoniae.

Linear Regression Equations To Predict β-Lactam, Macrolide, Lincosamide, and Fluoroquinolone MICs from Molecular Antimicrobial Resistance Determinants in Streptococcus pneumoniae.

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.

PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F.

PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F.

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.